Burning Rock Biotech (BNR) Interest Expenses (2019 - 2025)

Burning Rock Biotech (BNR) recorded quarterly Interest Expenses of -$2000.0 in Q4 2025, little changed quarter-over-quarter from -$2000.0 in Q3 2025.

Burning Rock Biotech (BNR) Interest Expenses (2019 - 2025) Analysis & Trends

Burning Rock Biotech's Interest Expenses history runs 4 years deep, the most recent figure standing at -$2000.0 for Q4 2025.

In Q4 2025, Interest Expenses changed N/A year-over-year to -$2000.0; the TTM figure through Dec 2025 stood at -$4000.0 (changed N/A YoY), while the FY2025 annual figure was -$4000.0, changed N/A from the prior year.
Interest Expenses was -$2000.0 for Q4 2025 at Burning Rock Biotech, roughly flat from -$2000.0 in the prior quarter.
In the past five years, Interest Expenses ranged from a high of -$2000.0 in Q3 2025 to a low of -$88000.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Waters	29,902.70 Bn	29,902.24 Bn	1.11 Bn	48.00 Mn
2	Thermo Fisher Scientific	175.99 Bn	172.74 Bn	7.74 Bn	354.00 Mn
3	Danaher	129.87 Bn	124.18 Bn	3.59 Bn	63.00 Mn
4	Idexx Laboratories	44.75 Bn	44.55 Bn	722.74 Mn	7.74 Mn
5	Agilent Technologies	37.52 Bn	35.72 Bn	990.00 Mn	25.00 Mn
6	Iqvia Holdings	30.91 Bn	28.94 Bn	1.36 Bn	192.00 Mn
7	Natera	30.21 Bn	29.11 Bn	696.04 Mn	892,000.00
8	Illumina	24.19 Bn	23.04 Bn	721.00 Mn	24.00 Mn
9	Mettler Toledo International	23.12 Bn	23.06 Bn	555.82 Mn	17.01 Mn
10	Burning Rock Biotech	22.35 Mn	-45.48 Mn	14.10 Mn	-2,000.00

Download Data